With a Bayer-Sanofi Executive Switch, Sanofi Creates 2 New Global Business UnitsAllbiopro2018-09-14T00:15:10+09:009월 14th, 2018|
Takeda Could Sell Some Shire Assets to Pay Down Deal DebtAllbiopro2018-09-14T00:14:13+09:009월 14th, 2018|
Report Sheds Light on Importance of Licensing Agreements in Biopharma IndustryAllbiopro2018-09-14T00:13:20+09:009월 14th, 2018|
Boehringer buys oncolytic virus startup ViraTherapeuticsAllbiopro2018-09-14T00:12:23+09:009월 14th, 2018|
Half of European studies fail to report results: BMJ reportAllbiopro2018-09-14T00:11:29+09:009월 14th, 2018|
Gilead taps gene editors at Precision BioSciences for hep B cure developmentAllbiopro2018-09-14T00:10:33+09:009월 14th, 2018|
Vital Therapies falls 88%, ditches liver treatment after phase 3 failAllbiopro2018-09-14T00:09:34+09:009월 14th, 2018|
Coda Biotherapeutics launches with $19M to build ‘tunable’ gene therapyAllbiopro2018-09-14T00:08:38+09:009월 14th, 2018|
Atreca bags $125M as solid tumor trial comes into viewAllbiopro2018-09-14T00:07:43+09:009월 14th, 2018|
Gilead, Galapagos’ filgotinib aces first phase 3, suggesting it can compete with AbbVie’s upadacitinibAllbiopro2018-09-14T00:06:55+09:009월 14th, 2018|
Bristol-Myers Squibb begins phase 3 enrollment after psoriasis drug shows high skin clearanceAllbiopro2018-09-14T00:05:59+09:009월 14th, 2018|
Former Gilead CMO Cheng joins Akero as CEO, as company moves HQAllbiopro2018-09-14T00:05:02+09:009월 14th, 2018|
Xenon frees itself of some XEN1101 milestone obligationsAllbiopro2018-09-14T00:04:09+09:009월 14th, 2018|
OncoResponse raises $40M for cancer patient-sourced antibodiesAllbiopro2018-09-14T00:03:14+09:009월 14th, 2018|
ImmusanT to develop Type 1 diabetes vaccine with JDRF backingAllbiopro2018-09-14T00:01:27+09:009월 14th, 2018|
Sanofi prepped for production after EU Nanobody successAllbiopro2018-09-14T00:00:33+09:009월 14th, 2018|
Exclusive: Samsung BioLogics poised to enter cell therapy spaceAllbiopro2018-09-13T23:59:35+09:009월 13th, 2018|
